A Study of Meropenem-Vaborbactam Versus Piperacillin/Tazobactam in Participants With Hospital-Acquired and Ventilator-Associated Bacterial Pneumonia

Conditions:   Hospital-Acquired Bacterial Pneumonia;   Ventilator-Associated Bacterial Pneumonia;   Hospital-Acquired Pneumonia;   Ventilator-Associated Pneumonia Interventions:   Drug: Meropenem-Vaborbactam;   Drug: Piperacillin/Tazobactam Sponsor:   The Medicines Company Not yet recruiting - verified December 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials